University of Hertfordshire

From the same journal

From the same journal

By the same authors

View graph of relations
Original languageEnglish
Number of pages13
Pages (from-to)212-224
JournalSynapse: journal & newsletter of the Association of Chartered Physiotherapists Interested in Neurology
Journal publication date1 Jun 1999
Publication statusPublished - 1 Jun 1999


The effects of a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine ((+)-MK-801) and a competitive NMDA antagonist, (+/-)-3-2-carboxypiperazin-4-yl-propyl-1-phosphonic acid (CPP) were compared in electrically evoked 5-HT release in the brain slices incorporating the substantia nigra pars reticulata (SNr) or the dorsal raphe nucleus (DRN) using fast cyclic voltammetry (FCV). Electrical stimulation of either the SNr or the DRN with 50 pulses at frequencies greater than 10 Hz generated signals that were indistinguishable from 5-HT. In the SNr, 0.6-60 mu M MK-801 concentration dependently potentiated stimulated 5-HT release. CPP 20 mu M or NMDA 100 mu M had no effect on 5-HT release evoked by electrical stimulation. In the SNr, 1 mu M fluvoxamine or 0.6-60 mu M MK-801 potentiated electrically evoked release of 5-HT. Pre-exposure to 20 mu M MK-801 inhibited the enhancing effects of 1 mu M fluvoxamine on electrically evoked 5-HT release in the SNr. In the DRN, the presence of 1 mu M fluvoxamine or 20 PM MK-801 weakly potentiated 5-HT release. In the presence of 1 PM methiothepin (a nonselective 5-HT1-2 antagonist), 1 mu M fluvoxamine or 20 mu M MK-801 were equipotent in potentiating the,concentration of 5-HT released in response to electrical stimulation. The T-1/2 values for 5-HT release following MK-801 or fluvoxamine administration were significantly increased. Potentiation of 5-HT release by MK-801 in the SNr and the DRN and lack of effect of either CPP or NMDA on 5-HT release or uptake argues against a role for NMDA receptors in modulation of 5-HT release. Inhibition of fluvoxamine induced potentiation of 5-HT signal in the presence of MK-801 suggests that MK-801 and fluvoxamine may interact at the level of the 5-HT transporter. (C) 1999 Wiley-Liss, Inc.

ID: 735976